LIFKEVO Trademark

Trademark Overview

On Wednesday, December 6, 2017, a trademark application was filed for LIFKEVO with the United States Patent and Trademark Office. The USPTO has given the LIFKEVO trademark a serial number of 87709788. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 7, 2021. This trademark is owned by Vertex Pharmaceuticals Incorporated. The LIFKEVO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cystic fibrosis
lifkevo

General Information

Serial Number87709788
Word MarkLIFKEVO
Filing DateWednesday, December 6, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 7, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 6, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cystic fibrosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 15, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVertex Pharmaceuticals Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameVertex Pharmaceuticals Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Monday, June 7, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 7, 2021ABANDONMENT - NO USE STATEMENT FILED
Saturday, November 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 6, 2020EXTENSION 5 GRANTED
Thursday, October 22, 2020EXTENSION 5 FILED
Monday, November 2, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 22, 2020TEAS EXTENSION RECEIVED
Sunday, June 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, June 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, June 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 27, 2020EXTENSION 4 GRANTED
Monday, April 27, 2020EXTENSION 4 FILED
Monday, April 27, 2020TEAS EXTENSION RECEIVED
Saturday, November 2, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 31, 2019EXTENSION 3 GRANTED
Thursday, October 31, 2019EXTENSION 3 FILED
Thursday, October 31, 2019TEAS EXTENSION RECEIVED
Thursday, May 2, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 30, 2019EXTENSION 2 GRANTED
Tuesday, April 30, 2019EXTENSION 2 FILED
Tuesday, April 30, 2019TEAS EXTENSION RECEIVED
Thursday, October 25, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 23, 2018EXTENSION 1 GRANTED
Tuesday, October 23, 2018EXTENSION 1 FILED
Tuesday, October 23, 2018TEAS EXTENSION RECEIVED
Friday, June 1, 2018ASSIGNED TO EXAMINER
Tuesday, May 1, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 6, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 6, 2018PUBLISHED FOR OPPOSITION
Wednesday, February 14, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 26, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 22, 2018ASSIGNED TO EXAMINER
Friday, December 15, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 9, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

lifkevo fibrosis cystic treatment preparations pharmaceutical